The Enterprise Value as of September 2024 (TTM) for AbCellera Biologics Inc. (ABCL) is 602.99M

According to AbCellera Biologics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 602.99M. This represents a change of -49.56% compared to the average of 1.20B of the last 4 quarters.

AbCellera Biologics Inc. (ABCL) Historical Enterprise Value (quarterly & annually)

How has ABCL Enterprise Value performed in the past?

The mean historical Enterprise Value of AbCellera Biologics Inc. over the last ten years is 5.86B. The current 602.99M Enterprise Value has changed 929.27% with respect to the historical average. Over the past ten years (40 quarters), ABCL's Enterprise Value was at its highest in in the September 2020 quarter at 15.58B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

AbCellera Biologics Inc. (ABCL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AbCellera Biologics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AbCellera Biologics Inc. (ABCL) Average Enterprise Value

How has ABCL Enterprise Value performed in the past?

The current Enterprise Value of AbCellera Biologics Inc. (ABCL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AbCellera Biologics Inc. (ABCL) Enterprise Value vs. Peers

How is ABCL’s Enterprise Value compared to its peers?

AbCellera Biologics Inc.’s Enterprise Value is greater than CohBar, Inc. (-4942363.00), greater than Hepion Pharmaceuticals, Inc. (2.24M), greater than Rain Therapeutics Inc. (7.16M), less than Krystal Biotech, Inc. (4.95B), greater than AVROBIO, Inc. (-85302404.00), greater than CureVac N.V. (390.67M), less than Reata Pharmaceuticals, Inc. (6.68B), less than Vir Biotechnology, Inc. (864.03M), greater than Propanc Biopharma, Inc. (1.07M), less than PTC Therapeutics, Inc. (2.17B), less than Sarepta Therapeutics, Inc. (13.28B), less than Iovance Biotherapeutics, Inc. (2.89B), less than Madrigal Pharmaceuticals, Inc. (4.91B),

Build a custom stock screener for AbCellera Biologics Inc. (ABCL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbCellera Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbCellera Biologics Inc. (ABCL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbCellera Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.